Clicky

Zydus Lifesciences Limited(ZYDUSLIFE)

Description: Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.


Keywords: Pharmaceutical Products Pain Active Pharmaceutical Ingredients Autoimmune Disease Inflammation Pain Management Pharmaceutical Industry In India Liver Disease Biological Products Pharmaceutical Industry Of Gujarat Animal Healthcare Products Consumer Wellness Products Zydus Wellness

Home Page: zyduslife.com

Zydus Corporate Park
Ahmedabad, 382481
India
Phone: 91 79 4804 0000


Officers

Name Title
Dr. Sharvil Pankajbhai Patel MD & Executive Director
Dr. Ganesh Narayan Nayak COO & Executive Director
Mr. Punit Patel President & CEO of America
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer
Mr. Arvind Bothra Head of Investor Relations
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer

Exchange: NSE

Country: IN : India

Currency: Indian Rupee (INR)

Forward PE: 21.5983
Trailing PE: 23.4749
Price-to-Book MRQ: 4.588
Price-to-Sales TTM: 4.6603
IPO Date:
Fiscal Year End: March
Full Time Employees: 26921
Back to stocks